Navigation Links
Neurologix Completes Additional $7 Million Financing
Date:12/6/2010

ceive approval from the FDA on its Investigational New Drug Application to commence a Phase 1 clinical trial for the treatment of epilepsy.
  • There is no assurance as to when, or if, the Company will be able to successfully complete the required preclinical testing of its gene therapy for the treatment of depression or Huntington's disease to enable it to file an Investigational New Drug Application with the FDA for permission to begin a Phase 1 clinical trial or that, if filed, such permission will be granted.

  • Other factors and assumptions not identified above could also cause the actual results to differ materially from those set forth in the forward-looking statements. Additional information about factors that could cause results to differ materially from management's expectations is found in the section entitled "Risk Factors" in the Company's 2009 Annual Report on Form 10-K. Although the Company believes these assumptions are reasonable, no assurance can be given that they will prove correct. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results. Further, the Company undertakes no obligation to update forward-looking statements after the date they are made or to conform the statements to actual results or changes in the Company's expectations.Contact: NeurologixMarc Panoff, 201-592-6451 Chief Financial Officer marcpanoff@neurologix.net
    '/>"/>

    SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
    2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
    3. Neurologix Reports Third Quarter 2010 Financial Results
    4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
    10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
    11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... PHILADELPHIA , Nov. 26, 2014  Cohen, ... on behalf of investors who purchased Nymox Pharmaceutical ... ) during the period from January 31, 2011 ... concerns whether Nymox and certain of its officers ... information in violation of Sections 10(b) and 20(a) ...
    (Date:11/26/2014)... Nov. 26, 2014   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and CEO of Regulus, will present a company ... Healthcare Conference at the New York Palace Hotel on ... presentation will be webcast at the time of the ...
    (Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
    Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
    ... Jayex – http://www.jayex.com , the healthcare ... of Med-Extranet ; its online healthcare ... online access to educational videos, digital posters and public ... waiting room screens . Med-Extranet is ...
    ... FRANCISCO, Jan. 19, 2011 Jennerex, Inc. (San ... development of first-in-class, targeted oncolytic products for cancer, ... the newly-created position of vice president, regulatory affairs. ... regulatory strategies and managing all aspects of regulatory ...
    Cached Medicine Technology:Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 2Digital Display System Specialist Jayex Launches Med-Extranet Online Media Library 3Jennerex Names Ursula Fritsch, PharmD, as Vice President, Regulatory Affairs 2
    (Date:11/28/2014)... The holiday season is fast approaching. As a ... collection of fashionable party dresses. What’s more, the company is ... brand new outfits; the special offer is valid until Dec. ... supplier and it has received a lot of requests for ... designed to flatter various body shapes; they are available in ...
    (Date:11/28/2014)... BambooFlooringChina.com has been recognized as a ... the business has announced its new strand woven ... discount on these new models. , Based on the ... without carpenter machines involved. It is crafted on strand ... for do-it-yourselfers without hard work on installation, also available ...
    (Date:11/28/2014)... November 28, 2014 Junk-A-Car ( http://www.junkacar.com ... expanding their service offerings to help drivers, especially those ... and Washington, D.C. metropolitan areas deal with the especially ... a large part of the country. , With the ... in hundreds of totaled, crashed and junk ...
    (Date:11/28/2014)... Gables, Florida (PRWEB) November 28, 2014 ... Thanksgiving, Turbana and Sendik’s will present Feeding America Eastern ... with Sendik’s Food Market to donate a portion of ... participated in Sendik’s promotion, “7 Days, 7 Ways to ... throughout fall, Fyffes pineapples were two for $4 and ...
    (Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, one ... a new treatment to her practice called Ultrashape that is ... to three inches in just six weeks. Ultrashape has been ... all, superior in results when compared to other types of ... can treat it,” said Dr. Walder. , According to ...
    Breaking Medicine News(10 mins):Health News:Trendy Party Dresses For The Coming Holiday Season From Balfleet.com 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Junk-A-Car Expanding Service to Assist U.S. Car Owners That May be Affected by Severe Winter Storms 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3
    ... won three competitive awards from the American Speech Language ... at its annual conference this week in San Diego. ... international candidates based on peer-reviewed measures of excellence. The ... and candidates this year. More than 12,000 people are ...
    ... years or longer before currently available blood tests will detect ... of Medicine scientists indicates. The analysis, which was restricted to ... types, will be published online Nov. 16 in Science ... as both bad and good news," said Sanjiv "Sam" Gambhir, ...
    ... The American Academy of Orthopaedic Surgeons (AAOS) Board of ... practice guideline (CPG) on "The Treatment of Supracondylar Humerus ... surgeon, medical director of the Trauma Program at the ... chair of the AAOS Work Group responsible for this ...
    ... 2020, the vast majority of adults in America will be ... diabetes or pre-diabetic conditions, according to projections presented by Northwestern ... Wednesday, Nov. 16, in Orlando. The AHA has ... health by 20 percent in 2020. However, if current trends ...
    ... the emerging field of nanomedicine a breathtaking technological revolution ... diseases? Or does it portend the release of dangerous ... in the body? A new review of more than ... is likely. It appears in ACS, journal Molecular ...
    ... up less produce the finest foie gras that rich, ... sometimes eaten as slices atop lightly toasted bread scientists ... Agricultural and Food Chemistry. Caroline Molette and colleagues ... foie gras, a traditional French dish, comes from its high ...
    Cached Medicine News:Health News:Awards honor UT Dallas researcher and Ph.D. students 2Health News:New Stanford model establishes guidelines for earlier cancer detection 2Health News:New Stanford model establishes guidelines for earlier cancer detection 3Health News:New Stanford model establishes guidelines for earlier cancer detection 4Health News:AAOS issues new clinical practice guideline for treating common elbow fractures in children 2Health News:On track to getting even fatter 2Health News:On track to getting even fatter 3
    ... The BiliChek measures total serum bilirubin ... no risk of infection compared to the ... Using light, BiliChek tests bilirubin levels without ... Only the replaceable plastic tip touches the ...
    ... 3900 Multi-Sample Osmometer is designed to ... to high volumes of samples. By ... technology for an accurate determination of ... throughput, the Advanced Instruments Model 3900 ...
    ... SSO typing technique utilises a generic PCR ... specific target region of an HLA locus. ... resulting amplicon to an array of Sequence ... membrane. The immobilisation of these probes is ...
    ... only a 20L sample size, which provides accurate ... convenience, the fully accessible probe design is easy ... only your most reliable option, it's the easiest ... a disposable sample tube, then place the tube ...
    Medicine Products: